Genmab A (GMAB) Receivables - Net (2023 - 2025)
Historic Receivables - Net for Genmab A (GMAB) over the last 3 years, with Q4 2025 value amounting to $1.1 billion.
- Genmab A's Receivables - Net rose 2193.55% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 2193.55%. This contributed to the annual value of $1.1 billion for FY2025, which is 2193.55% up from last year.
- Genmab A's Receivables - Net amounted to $1.1 billion in Q4 2025, which was up 2193.55% from $930.0 million recorded in Q4 2024.
- Genmab A's Receivables - Net's 5-year high stood at $1.1 billion during Q4 2025, with a 5-year trough of $743.0 million in Q4 2023.
- Moreover, its 3-year median value for Receivables - Net was $930.0 million (2024), whereas its average is $935.7 million.
- Its Receivables - Net has fluctuated over the past 5 years, first soared by 2516.82% in 2024, then soared by 2193.55% in 2025.
- Over the past 3 years, Genmab A's Receivables - Net (Quarter) stood at $743.0 million in 2023, then rose by 25.17% to $930.0 million in 2024, then rose by 21.94% to $1.1 billion in 2025.
- Its Receivables - Net stands at $1.1 billion for Q4 2025, versus $930.0 million for Q4 2024 and $743.0 million for Q4 2023.